Stock listing
Santhera Pharmaceuticals Holding Ag
Selected listing: SANN · SIX · CHF · CH
Santhera Pharmaceuticals Holding Ag (SIX Swiss: SANN), Health Technology. Latest release Jul 13, 2026: Santhera Expands Biomedica Agreement to Extend AGAMREE®…
- Ticker
- SIX Swiss: SANN
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- SIX Swiss
- Currency
- CHF
About Santhera Pharmaceuticals Holding Ag
Santhera Pharmaceuticals Holding AG is a public company listed on the Swiss market under the ticker SANN. Santhera focuses on developing innovative therapies for rare diseases, particularly in the field of neuromuscular disorders.
Latest news from Santhera Pharmaceuticals Holding Ag
Santhera Expands Biomedica Agreement to Extend AGAMREE® (Vamorolone) Distribution Across Central Asia and the Caucasus
July 13, 2026
Santhera Announces Orphan Drug and Priority Review Designations for AGAMREE® (Vamorolone) in South Korea
June 2, 2026
Santhera Proposes Dr. Srishti Gupta as New Member of the Board of Directors
April 30, 2026
Santhera Announces Positive AIFA Board Decision on Reimbursement of AGAMREE® (vamorolone) in Italy
April 28, 2026
Santhera Pharmaceuticals Full Year Results for the Year Ended 31 December 2025
April 28, 2026
Events
Replays
Santhera Pharmaceuticals Holding AG (0QN1) Q2 2026 Earnings Call
Wed, Sep 30, 2026 · 08:00 AM ET
WatchSanthera Pharmaceuticals Holding AG (0QN1) Q4 2025 Earnings Call
Tue, Apr 28, 2026 · 08:00 AM ET
WatchSanthera Pharmaceuticals Holding AG (0QN1) Q2 2025 Earnings Call
Tue, Sep 23, 2025 · 08:00 AM ET
Watch
Research Santhera Pharmaceuticals Holding Ag
Santhera Pharmaceuticals Holding Ag company profile
View the public company page for Santhera Pharmaceuticals Holding Ag on 6ix.
Santhera Pharmaceuticals Holding Ag news
Read company news and market updates connected to Santhera Pharmaceuticals Holding Ag.
Santhera Pharmaceuticals Holding Ag investor events
Find investor webinars, events, and replay context for Santhera Pharmaceuticals Holding Ag.
Alternate listings
SPHDF:OTC
US · USD
Alternate listing for Santhera Pharmaceuticals Holding Ag; the primary context on this page is SANN:SIX.
0QN1:LSE
GB · CHF
Alternate listing for Santhera Pharmaceuticals Holding Ag; the primary context on this page is SANN:SIX.
S3F0:GETTEX
DE · EUR
Alternate listing for Santhera Pharmaceuticals Holding Ag; the primary context on this page is SANN:SIX.
A3EJMQ:LSX
DE · EUR
Alternate listing for Santhera Pharmaceuticals Holding Ag; the primary context on this page is SANN:SIX.
A3EJMQ:LS
DE · EUR
Alternate listing for Santhera Pharmaceuticals Holding Ag; the primary context on this page is SANN:SIX.
SANNZ:AQUISUK
GB · CHF
Alternate listing for Santhera Pharmaceuticals Holding Ag; the primary context on this page is SANN:SIX.
S3F0:BX
CH · CHF
Alternate listing for Santhera Pharmaceuticals Holding Ag; the primary context on this page is SANN:SIX.
S3F0:TRADEGATE
DE · EUR
Alternate listing for Santhera Pharmaceuticals Holding Ag; the primary context on this page is SANN:SIX.
S3F0:DUS
DE · EUR
Alternate listing for Santhera Pharmaceuticals Holding Ag; the primary context on this page is SANN:SIX.
S3F0:FWB
DE · EUR
Alternate listing for Santhera Pharmaceuticals Holding Ag; the primary context on this page is SANN:SIX.
S3F0:HAM
DE · EUR
Alternate listing for Santhera Pharmaceuticals Holding Ag; the primary context on this page is SANN:SIX.
S3F0:MUN
DE · EUR
Alternate listing for Santhera Pharmaceuticals Holding Ag; the primary context on this page is SANN:SIX.